| 12391697 |
Condensed bi-heterocycles as inhibiting agents for Bruton's tyrosine kinase |
Jürgen Schulz, Brian T. Hopkins, Bin Ma, Robin Prince, Marta Nevalainen |
2025-08-19 |
|
| 12240838 |
Inhibiting agents for Bruton's tyrosine kinase |
Brian T. Hopkins, Bin Ma, Robin Prince, Jürgen Schulz, Marta Nevalainen |
2025-03-04 |
|
| 12240839 |
Cyclobutyl dihydroquinoline sulfonamide compounds |
Benjamin C. Milgram, Haoxuan Wang, Alan H. CHERNEY |
2025-03-04 |
|
| 11858926 |
Inhibiting agents for bruton's tyrosine kinase |
Brian T. Hopkins, Bin Ma, Robin Prince, Joseph P. Lyssikatos, Fengmei Zheng +2 more |
2024-01-02 |
$63,477,000 |
| 11807634 |
Cyclopropyl dihydroquinoline sulfonamide compounds |
Benjamin C. Milgram, John Stellwagen, Wei Zhao, Alan H. CHERNEY |
2023-11-07 |
$187,257,000 |
| 11427577 |
Inhibiting agents for Bruton's tyrosine kinase |
Brian T. Hopkins, Bin Ma, Robin Prince, Joseph P. Lyssikatos, Fengmei Zheng +2 more |
2022-08-30 |
$41,858,000 |
| 10961237 |
Inhibiting agents for Bruton's tyrosine kinase |
Brian T. Hopkins, Bin Ma, Robin Prince, Joseph P. Lyssikatos, Fengmei Zheng +2 more |
2021-03-30 |
$305,557,000 |
| 10899753 |
Inhibiting agents for Bruton's tyrosine kinase |
Brian T. Hopkins, Bin Ma, Robin Prince, Jürgen Schulz, Marta Nevalainen +1 more |
2021-01-26 |
$635,505,000 |
| 10227341 |
Inhibiting agents for bruton's tyrosine kinase |
Brian T. Hopkins, Bin Ma, Robin Prince, Joseph P. Lyssikatos |
2019-03-12 |
$471,484,000 |
| 10189829 |
Inhibiting agents for Bruton's tyrosine kinase |
Brian T. Hopkins, Bin Ma, Robin Prince, Joseph P. Lyssikatos, Fengmei Zheng +2 more |
2019-01-29 |
$157,806,000 |
| 9776995 |
Bicyclic sulfonamide compounds as sodium channel inhibitors |
Matthew Weiss, Erin F. Dimauro, Thomas A. Dineen, Russell Graceffa, Angel Guzman-Perez +5 more |
2017-10-03 |
$315,293,000 |
| 9458152 |
Bicyclic sulfonamide compounds as sodium channel inhibitors |
Matthew Weiss, Alessandro Boezio, Christiane Boezio, John R. BUTLER, Margaret Chu-Moyer +12 more |
2016-10-04 |
$255,050,000 |
| 9346798 |
Dihydrobenzoxazine and tetrahydroquinoxaline sodium channel inhibitors |
Christiane Boezio, Alessandro Boezio, Howard Bregman, Nagasree Chakka, James R. Coats +8 more |
2016-05-24 |
$192,745,000 |
| 9212182 |
Bicyclic sulfonamide compounds as sodium channel inhibitors |
Matthew Weiss, Alessandro Boezio, Christiane Boezio, John R. BUTLER, Margaret Chu-Moyer +12 more |
2015-12-15 |
$614,183,000 |
| 9079902 |
Heteroaryl sodium channel inhibitors |
Thomas A. Dineen, Hanh Nho Nguyen, Matthew Weiss |
2015-07-14 |
$591,404,000 |
| 9012446 |
Amino-oxazines and amino-dihydrothiazine compounds as beta-secretase modulators and methods of use |
Jian Chen, Wenge Zhong, Patricia Lopez, Ryan White, Matthew Weiss +6 more |
2015-04-21 |
$150,202,000 |
| 9012443 |
Bicyclic aryl and heteroaryl sodium channel inhibitors |
Christiane Boezio, Howard Bregman, James R. Coats, Erin F. Dimauro, Thomas A. Dineen +11 more |
2015-04-21 |
$150,202,000 |
| 8883782 |
Spiro-tetracyclic ring compounds as beta-secretase modulators and methods of use |
Yuan Cheng, Ryan White, Albert Amegadzie, James Brown, Alan C. Cheng +19 more |
2014-11-11 |
$176,830,000 |
| 8557816 |
Aurora kinase modulators and method of use |
Stephanie Geuns-Meyer, Victor J. Cee, Laurie B. Schenkel, Ryan White |
2013-10-15 |
$167,714,000 |
| 8426447 |
Spiro-tricyclic ring compounds as beta-secretase modulators and methods of use |
Ryan White, Albert Amegadzie, Marian C. Bryan, Jian Chen, Alan C. Cheng +14 more |
2013-04-23 |
$145,762,000 |
| 7776857 |
Aurora kinase modulators and method of use |
Victor J. Cee, Holly L. Deak, Bingfan Du, Stephanie Geuns-Meyer, Brian L. Hodous +8 more |
2010-08-17 |
$81,738,000 |